|
1
|
Ministry of Health, Labour and Welfare.
Annual Health, Labour and Welfare Report 2011–2012. http://www.mhlw.go.jp/toukei/.
Accessed September 6, 2012
|
|
2
|
Asher V, Lee J and Bali A: Preoperative
serum albumin is an independent prognostic predictor of survival in
ovarian cancer. Med Oncol. 29:2005–2009. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blackburn GL, Bistrian BR, Maini BS,
Schlamm HT and Smith MF: Nutritional and metabolic assessment of
the hospitalized patient. J Parenter Enteral Nutr. 1:11–22. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Inoue Y, Nezu R, Matsuda H, Takagi Y and
Okada A: Rapid turnover proteins as a prognostic indicator in
cancer patients. Surg Today. 25:498–506. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valandingham S, Spiekerman AM and Newmark
SR: Prealbumin: a parameter of visceral protein levels during
albumin infusion. J Parenter Enteral Nutr. 6:230–231. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Delpeuch F, Cornu A and Chevalier P: The
effect of iron-deficiency anaemia on two indices of nutritional
status, prealbumin and transferrin. Br J Nutr. 43:375–379. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mears E: Outcome of continuous process
improvement of a nutritional care program incorporating serum
prealbumin measurements. Nutrition. 12:479–484. 1996. View Article : Google Scholar
|
|
8
|
McMillan DC, Canna K and McArdle CS:
Systemic inflammatory response predicts survival following curative
resection of colorectal cancer. Br J Surg. 90:215–219. 2003.
View Article : Google Scholar
|
|
9
|
Pierce BL, Ballard-Barbash R, Bernstein L,
Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland
FD, Sorensen BE, McTiernan A and Ulrich CM: Elevated biomarkers of
inflammation are associated with reduced survival among breast
cancer patients. J Clin Oncol. 27:3437–3444. 2009. View Article : Google Scholar
|
|
10
|
Kodama J, Miyagi Y, Seki N, Tokumo K,
Yoshinouchi M, Kobashi Y, Okuda H and Kudo T: Serum C-reactive
protein as a prognostic factor in patients with epithelial ovarian
cancer. Eur J Obstet Gynecol Reprod Biol. 82:107–110. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Witkowska AM: On the role of sIL-2R
measurements in rheumatoid arthritis and cancers. Mediators
Inflamm. 3:121–130. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gonda K, Shibata M, Shimura T, Machida T,
Suzuki S, Nakamura I, Ohki S, Sakurai K, Ohto H, Tomira R and
Takenoshita S: Serum soluble interleukin-2 receptor is increased in
malnourished and immunosuppressed patients with gastric and
colorectal cancer: Possible influence of myeloid-derived suppressor
cells. World J Oncol. 3:158–164. 2012.
|
|
13
|
Park H, Li Z, Yang XO, Chang SH, Nurieva
R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q and Dong C: A distinct
lineage of CD4 T cells regulates tissue inflammation by producing
interleukin 17. Nat Immunol. 6:1133–1141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Z, Tato CM, Muul L, Laurence A and
O’Shea JJ: Distinct regulation of interleukin-17 in human T helper
lymphocytes. Arthritis Rheum. 56:2936–2946. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Santarlasci V, Maggi L, Capone M, Frosali
F, Querci V, De Palma R, Liotta F, Cosmi L, Maggi E, Romagnani S
and Annunziato F: TGF-beta indirectly favors the development of
Th17 cells by inhibiting Th1 cells. Eur J Immunol. 39:207–215.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kolls JK and Lindén A: Interleukin-17
family members and inflammation. Immunity. 21:467–476. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yazawa T, Shibata M, Gonda K, Machida T,
Suzuki S, Kenjo A, Nakamura I, Tsuchiya T, Koyama Y, Sakurai K, et
al: Increased IL-17 production correlates with both
immunosuppression involving MDSC and nutritional impairment in
patients with various gastrointestinal cancers. Mol Clin Oncol.
1:675–679. 2013.
|
|
18
|
Watanabe T, Shibata M, Nishiyama H, Soeda
S, Furukawa S, Gonda K, Takenoshita S and Fujimori K: Elevated
serum levels of vascular endothelial growth factor is effective as
a marker for malnutrition and inflammation in patients with ovarian
cancer. Biomed Rep. 1:197–201. 2013.PubMed/NCBI
|
|
19
|
Goldmann E: The growth of malignant
disease in man and the lower animals, with special reference to the
vascular system. Proc R Soc Med. 1:1–13. 1908.PubMed/NCBI
|
|
20
|
Rubin H: Cancer cachexia: its correlations
and causes. Proc Natl Acad Sci USA. 100:5384–5389. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deans C and Wigmore SJ: Systemic
inflammation, cachexia and prognosis in patients with cancer. Curr
Opin Clin Nutr Metab Care. 8:265–269. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mantovani G, Macciò A, Madeddu C, Serpe R,
Antoni G, Massa E, Dessì M and Panzone F: Phase II nonrandomized
study of the efficacy and safety of COX-2 inhibitor celecoxib on
patients with cancer cachexia. J Mol Med (Berl). 88:85–92. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fearon KC, Von Meyenfeldt MF, Moses AG,
Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J,
Barber MD, et al: Effect of a protein and energy dense N-3 fatty
acid enriched oral supplement on loss of weight and lean tissue in
cancer cachexia: a randomised double blind trial. Gut.
52:1479–1486. 2003. View Article : Google Scholar
|
